<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>Moody Capital Solutions News Releases</title>
		<link>https://feeds.newsfilecorp.com/company/12660</link>
		<description>Latest news from Moody Capital Solutions, as distributed by TMX Newsfile.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Wed, 09 Sep 2026 04:01:12 -0400</lastBuildDate>
		<image>
			<url>https://images.newsfilecorp.com/logos/12660.jpg</url>
			<title>Moody Capital Solutions News Releases</title>
			<link>https://feeds.newsfilecorp.com/company/12660</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/company/12660"/>
		<item xml:lang="en">
			<title>BioVaxys Technology Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference</title>
			<link>https://www.newsfilecorp.com/release/313350/BioVaxys-Technology-Corp.-to-Present-at-the-Moody-Capital-Solutions-2026-Disruptive-Growth-Life-Sciences-Conference</link>
			<description>Vancouver, British Columbia--(Newsfile Corp. - September 8, 2026) - BioVaxys Technology Corp. (OTC Pink: BVAXF) (CSE: BIOV) (FSE: 5LB), ("BioVaxys" or the "Company") a clinical-stage biopharmaceutical company focused on the development of durable, single-dose, vaccines for safe, scalable, and long-lasting immune protection in oncology, infectious disease, and immune dysfunctions, is pleased to announce its participation at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences...&lt;img src="https://api.newsfilecorp.com/newsinfo/313350/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 08 Sep 2026 13:30:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/313350</guid>
		</item>
		<item xml:lang="en">
			<title>Quantum eMotion Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference</title>
			<link>https://www.newsfilecorp.com/release/313201/Quantum-eMotion-Corp.-to-Present-at-the-Moody-Capital-Solutions-2026-Disruptive-Growth-Life-Sciences-Conference</link>
			<description>Montreal, Quebec--(Newsfile Corp. - September 8, 2026) - Quantum eMotion Corp. (TSXV: QNC), a Quantum Cybersecurity company, is pleased to announce its participation at the upcoming Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference, taking place September 9–10, 2026, in New York City. Francis Bellido, CEO, will be attending the conference, delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors.    Date: Thursday, September 10,...&lt;img src="https://api.newsfilecorp.com/newsinfo/313201/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 08 Sep 2026 09:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/313201</guid>
		</item>
		<item xml:lang="en">
			<title>Decoy Therapeutics to Present at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference</title>
			<link>https://www.newsfilecorp.com/release/312753/Decoy-Therapeutics-to-Present-at-the-Moody-Capital-Solutions-2026-Disruptive-Growth-Life-Sciences-Conference</link>
			<description>Rick Pierce, Chief Executive Officer, to deliver an investor presentation on Thursday, September 10 in New York Cambridge, Massachusetts--(Newsfile Corp. - September 8, 2026) - Decoy Therapeutics, Inc. (NASDAQ: DCOY), a biotechnology company developing Designable Multi-Antivirals (D-MAVs™), a new category of antivirals engineered to work across many viruses, today announced that Rick Pierce, Chief Executive Officer, will present at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life...&lt;img src="https://api.newsfilecorp.com/newsinfo/312753/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 08 Sep 2026 09:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/312753</guid>
			<atom:subtitle>Rick Pierce, Chief Executive Officer, to deliver an investor presentation on Thursday, September 10 in New York</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Eco Wave Power to Present at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference</title>
			<link>https://www.newsfilecorp.com/release/313268/Eco-Wave-Power-to-Present-at-the-Moody-Capital-Solutions-2026-Disruptive-Growth-Life-Sciences-Conference</link>
			<description>Founder and CEO Inna Braverman to present Eco Wave Power's global expansion and growing role in powering next-generation AI infrastructure New York, New York--(Newsfile Corp. - September 8, 2026) - Eco Wave Power Global AB (publ) (NASDAQ: WAVE) ("Eco Wave Power" or the "Company"), a pioneering onshore wave energy technology company, today announced its participation in the upcoming Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference, taking place September 9-10, 2026, in...&lt;img src="https://api.newsfilecorp.com/newsinfo/313268/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 08 Sep 2026 08:30:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/313268</guid>
			<atom:subtitle>Founder and CEO Inna Braverman to present Eco Wave Power's global expansion and growing role in powering next-generation AI infrastructure</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference</title>
			<link>https://www.newsfilecorp.com/release/312850/CytoSorbents-to-Present-at-the-Moody-Capital-Solutions-2026-Disruptive-Growth-Life-Sciences-Conference</link>
			<description>Princeton, New Jersey--(Newsfile Corp. - September 4, 2026) - CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, is pleased to announce its participation at the upcoming Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference, taking place September 9-10, 2026, in New York City. Dr. Phillip Chan, CEO and Peter Mariani, CFO will be attending the conference,...&lt;img src="https://api.newsfilecorp.com/newsinfo/312850/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Fri, 04 Sep 2026 09:09:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/312850</guid>
		</item>
		<item xml:lang="en">
			<title>Cyabra Ltd to Present at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference</title>
			<link>https://www.newsfilecorp.com/release/312968/Cyabra-Ltd-to-Present-at-the-Moody-Capital-Solutions-2026-Disruptive-Growth-Life-Sciences-Conference</link>
			<description>New York, New York--(Newsfile Corp. - September 4, 2026) - Cyabra, Inc. (NASDAQ: CYAB) ("Cyabra" or the "Company"), a company whose artificial intelligence ("AI")-powered platform helps governments and enterprises detect coordinated manipulation and protect digital trust, is pleased to announce its participation at the upcoming Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference, taking place September 9-10, 2026, in New York City. Dan Brahmy, Co-Founder and Chief Executive...&lt;img src="https://api.newsfilecorp.com/newsinfo/312968/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Fri, 04 Sep 2026 09:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/312968</guid>
		</item>
		<item xml:lang="en">
			<title>FARADAY FUTURE to Present at The Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference</title>
			<link>https://www.newsfilecorp.com/release/312702/FARADAY-FUTURE-to-Present-at-The-Moody-Capital-Solutions-2026-Disruptive-Growth-Life-Sciences-Conference</link>
			<description>New York, New York--(Newsfile Corp. - September 4, 2026) - FARADAY FUTURE (NASDAQ: FFAI), Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, is pleased to announce its participation at the upcoming Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference, taking place September 9–10, 2026, in New York City. Jerry Wang, Global Executive Chairman of Faraday Future, will...&lt;img src="https://api.newsfilecorp.com/newsinfo/312702/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Fri, 04 Sep 2026 06:30:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/312702</guid>
		</item>
		<item xml:lang="en">
			<title>Mid-Atlantic BioTherapeutics, Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference</title>
			<link>https://www.newsfilecorp.com/release/312594/MidAtlantic-BioTherapeutics-Inc.-to-Present-at-the-Moody-Capital-Solutions-2026-Disruptive-Growth-Life-Sciences-Conference</link>
			<description>Doylestown, Pennsylvania--(Newsfile Corp. - September 3, 2026) -  Mid-Atlantic BioTherapeutics, Inc. (MABT), a pharmaceutical company focused on the clinical development and commercialization of novel therapeutic approaches using AI-enabled technologies, is pleased to announce its participation at the upcoming Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference, taking place September 9-10, 2026, in New York City. David Horn, M.D., Chief Executive Officer, will be attending...&lt;img src="https://api.newsfilecorp.com/newsinfo/312594/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Thu, 03 Sep 2026 09:30:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/312594</guid>
		</item>
		<item xml:lang="en">
			<title>Zeo Energy Corp. To Present at The Moody Capital Disruptive Growth &amp; Life Sciences Conference on September 10, 2026</title>
			<link>https://www.newsfilecorp.com/release/312386/Zeo-Energy-Corp.-To-Present-at-The-Moody-Capital-Disruptive-Growth-Life-Sciences-Conference-on-September-10-2026</link>
			<description>New Port Richey, Florida--(Newsfile Corp. - September 1, 2026) - Zeo Energy Corp. (NASDAQ: ZEO) ("Zeo," "Zeo Energy," or the "Company"), a provider of residential solar and commercial long-duration energy-storage solutions, is confirmed to present at the Moody Capital Disruptive Growth &amp; Life Sciences Conference, which is being held September 9-10 at The Westin New York Grand Central in New York, NY.Zeo's CEO, Tim Bridgewater is scheduled to present on Thursday, September 10th at 11:55 a.m....&lt;img src="https://api.newsfilecorp.com/newsinfo/312386/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 01 Sep 2026 09:45:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/312386</guid>
		</item>
		<item xml:lang="en">
			<title>The LGL Group, Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference</title>
			<link>https://www.newsfilecorp.com/release/312384/The-LGL-Group-Inc.-to-Present-at-the-Moody-Capital-Solutions-2026-Disruptive-Growth-Life-Sciences-Conference</link>
			<description>Arlington, Virginia--(Newsfile Corp. - September 1, 2026) -  The LGL Group, Inc. (NYSE American: LGL) ("LGL Group" or the "Company"), a holding company focused on business operations and merchant investment, is pleased to announce its participation at the upcoming Moody Capital Solutions 2026 Disruptive Growth &amp; Life Sciences Conference, taking place September 9-10, 2026, in New York City. Jason Lamb, Chief Executive Officer, will be attending the conference, delivering an investor...&lt;img src="https://api.newsfilecorp.com/newsinfo/312384/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 01 Sep 2026 09:23:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/312384</guid>
		</item>
	</channel>
</rss>
